10 Best Mid Cap Biotech Stocks to Buy
On March 6, Jared Holz, Mizuho health care equity strategist, appeared on CNBC's 'Power Lunch' to discuss investing in biotech and the oversaturation in the sector.
Roivant Sciences Ltd. (ROIV)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | QVT Financial Daniel Gold | 65,793,779 | $778,340,406 | 69.36% | |
| 2. | Viking Global Andreas Halvorsen | 47,809,960 | $565,591,827 | -12% | 1.83% |
| 3. | Rubric Capital Management David Rosen | 20,000,000 | $236,600,000 | -11% | 3.03% |
| 4. | Two Seas Capital Sina Toussi | 10,167,807 | $120,285,157 | +5% | 10.39% |
| 5. | Woodline Partners Michael Rockefeller And Karl Kroeker | 6,131,948 | $72,540,945 | -30% | 0.49% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.00 | 4,000,000 | Large Shareholder | 102,849,443 | 2022-11-10 | Filing | |
| $3.91 | 8,600 | Large Shareholder | 98,849,443 | 2022-04-25 | Filing | |
| $3.83 | 31,685 | Large Shareholder | 98,840,843 | 2022-04-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.82 | 434,478 | 1,127,290 | 2025-03-24 | Filing | ||
| $11.06 | 315,522 | 959,457 | 2025-03-20 | Filing | ||
| $10.65 | 100,000 | 896,869 | 2025-02-20 | Filing | ||
| $10.43 | 227,500 | 163,264 | 2025-02-13 | Filing | ||
| $10.42 | 218,041 | 896,869 | 2025-02-13 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 62,057,537 | $734,140,663 | 6.44% | |
| 2. | 49,301,583 | $583,237,729 | 0.03% | |
| 3. | 44,087,287 | $521,552,605 | 0% | |
| 4. | 42,157,531 | $498,723,591 | 0.01% | |
| 5. | 34,615,073 | $409,496,322 | 0.02% |
News See All
10 Best Stocks to Buy According to Billionaire David Einhorn
David Einhorn is a highly regarded hedge fund manager, who co-founded Greenlight Capital in 1996.
Does Roivant (ROIV) Offer an Attractive Risk Reward Opportunity?
Tourlite Capital Management, an investment management firm, released its fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Cash-Rich Mid Cap Stocks To Buy Now
Cash flow is the money moving in and out of a business over a set period. It is important because it shows how much cash a company actually has on hand, rather than just looking at profits on paper.
10 Cheap Biotech Stocks to Invest in Now
Biotechnology stocks are among the most volatile in the market due to their high risk.
Roivant Sciences Ltd. (NASDAQ:ROIV) Q3 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to a Roivant Sciences Ltd. second quarter 2024 earnings call. At this time, all participants are in a listen-only mode.
Billionaire Andreas Halvorsen's Top 15 Long-Term Stock Picks
Andreas Halvorsen is a prominent Norwegian hedge fund manager and the co-founder of Viking Global, one of the most successful equity-focused hedge funds in the world.
12 Best Medical Stocks To Buy Under $20
The medical industry plays a crucial role in ensuring the health and safety of populations.
10 Firms End 2024 Stronger With Impressive Gains
The Dow Jones Industrial Average dipped by 0.07 percent, the S&P 500 shed 0.43 percent, and the Nasdaq Composite declined by 0.90 percent.
Several Positive Developments Lifted Roivant (ROIV) in Q3
Tourlite Capital Management, an investment management firm, released its third quarter 2024 investor letter, a copy of which can be downloaded here.